Foundations of Originator and Biosimilar Biologics: for Patients and Caregivers

Module 1 - Understanding Biologics and Biosimilars

Learning Objectives:
1. Describe biologic medications, including how they are made and how they are used in clinical practice

2. Describe biosimilar biologics, including how they differ from other generic medications and why they are used in clinical practice

3.Compare and contrast biologic and biosimilar medications

Module 2 - Regulatory Approval Process

Learning Objectives:
1. Describe Health Canada's approval process for biosimilar biologic use and sale in Canada

2. Describe the safety and monitoring activities of biosimilar biologics, including the similarities between originator and biosimilar biologics

3. Explain the purpose of and the steps to find a product monograph on biosimilars

4. Describe the indications for originator and biosimilar biologics

5. Distinguish between interchangeability and switching between originator and biosimilar biologics.

Module 3 - Patient Access

Learning Objectives:
1. Understand the significance and use of biosimilars in certain people livin with diseases

2. Describe how biosimilar biologics are paid for in Canada

3. Describe Patient Support Programs (PSPs) and their role in helping patients coordinate cost and administration of biosiilar biologics

4. Describe the administration of biologics and possible changes when a patient is switched to a biosimilar

Module 4 - Discussing Biosimilars with your Health care Provider

Learning Objectives:
1. Explain how biosimilar use is monitored in Canada with respect to side effects and adverse drug reactions

2. Describe common facts about biosimilar biologics to become more familiar with them

3. Gain confidence in talking to your healthcare provider and others about biosimilar biologics